Assessment of Pembrolizumab Therapy for the Treatment of Microsatellite Instability–High Gastric or Gastroesophageal Junction Cancer Among Patients in the KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 Clinical Trials
JAMA Oncology | April 1, 2021 | Volume: 7 | Issue: 6 | Pages: 895
10.1001/jamaoncol.2021.0275
| PMID 33792646